Kidney Walk LaceUp 2020: National Kidney Foundation and LogistiCare Team Up: Walkers Can Join from Their Homes

Kidney Walk LaceUp: Teaming Up! LogistiCare, the nation’s largest non-emergency medical transportation company, today announced it is lacing-up with the National Kidney Foundation (NKF) as a National Multi-Market Sponsor of the Kidney Walk, which raises funds to support kidney health and improve the lives of the 37 million people in the United States affected by kidney disease. To help keep kidney patients, and those who care for them, safe during the national pandemic, this year’s Kidney Walk has transitioned to a new, virtual format.

“LogistiCare is committed to serving kidney patients – it’s part of who we are and what we believe,” said Daniel E. Greenleaf, President and Chief Executive Officer of LogistiCare. “During the pandemic, our services have become even more important, helping safely transport people to dialysis and necessary healthcare appointments. Our most important role is serving and giving back, and we are proud to partner with NKF on the Kidney Walk and support the new virtual format.”

Kidney Walk LaceUp represents an opportunity for participants to come together in a time of isolation and demonstrate their shared commitment to the lives of kidney patients and their loved ones, while still staying safe during the ongoing pandemic. Walkers can join from their homes, backyard, or local park and still help save lives.

“Now more than ever, nonprofits need the support of our corporate partners,” said Kevin Longino, CEO and kidney transplant patient. “COVID-19 has been devastating to kidney patients and we’ve been working nonstop to ensure they have access to safe dialysis and kidney transplantation, home dialysis, telehealth visits, and home lab draws, which are critically important to keeping our patient population safe. We’re grateful to LogistiCare for their continued commitment to helping us protect kidney patients, especially during these challenging times.”

The Kidney Walk is the nation’s largest fundraiser to fight kidney disease. Held in more than 70 communities, more than 55,000 walkers join NKF to raise more than $9 million to help kidney patients and their families each year. More than 81 cents of every dollar donated directly supports NKF programs and services. This year’s new, virtual format will enable those sheltering in place or social distancing to still participate and raise critically needed funds for kidney patients.

In addition to Kidney Walks, LogistiCare also holds an annual Service Day celebration that includes speeches and testimonials from patients battling kidney disease as well as doctors and representatives from the National Kidney Foundation. Over the past five years, LogistiCare and its employees have donated and raised more than $700,000 to help kidney patients.

Get all the Kidney Walk LaceUp details here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”